Sensei Biotherapeutics, Inc. (SNSE)
12.60
-0.40
(-3.08%)
USD |
NASDAQ |
Jun 09, 14:39
Sensei Biotherapeutics SG&A Expense (Quarterly) : 0.00 for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | 48.80M |
| Atossa Therapeutics, Inc. | 5.091M |
| Acurx Pharmaceuticals, Inc. | 1.374M |
| Xilio Therapeutics, Inc. | 6.928M |
| Onconetix, Inc. | 2.039M |